Published on in Vol 23, No 7 (2021): July
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/26813, first published
.
Journals
- Miller H, Plante T, Gleason K, Charleston J, Mitchell C, Miller E, Appel L, Juraschek S. A/B design testing of a clinical trial recruitment website: A pilot study to enhance the enrollment of older adults. Contemporary Clinical Trials 2021;111:106598 View
- Petrini C, Mannelli C, Riva L, Gainotti S, Gussoni G. Decentralized clinical trials (DCTs): A few ethical considerations. Frontiers in Public Health 2022;10 View
- de Jong A, van Rijssel T, Zuidgeest M, van Thiel G, Askin S, Fons‐Martínez J, De Smedt T, de Boer A, Santa‐Ana‐Tellez Y, Gardarsdottir H. Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective. Clinical Pharmacology & Therapeutics 2022;112(2):344 View
- Santa-Ana-Tellez Y, Lagerwaard B, de Jong A, Gardarsdottir H, Grobbee D, Hawkins K, Heath M, Zuidgeest M. Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus. Drug Discovery Today 2023;28(4):103520 View
- Le Prell C, Brewer C, Campbell K. The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear. The Journal of the Acoustical Society of America 2022;152(1):470 View
- Le Prell C, Clavier O, Bao J. Noise-induced hearing disorders: Clinical and investigational tools. The Journal of the Acoustical Society of America 2023;153(1):711 View
- Unger J, Stires H, Levit L, Stewart M, McKelvey B, Canin B, Dressler E, Flaherty K, Fredette P, Jones L, McCann P, Miller T, Onitilo A, Palmieri F, Patel T, Paul R, Smith G, Bruinooge S, Garrett-Mayer E, Lei X, Alva A, Schenkel C. Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality. JCO Oncology Practice 2023;19(10):907 View
- Dimitrova M, Hristov R, Djemadan A, Gaytandzieva I. Decentralized Clinical Trials – Current Environment, Potential Barriers and Facilitators for Implementation and Risk Mitigation: A Review of the Literature. Acta Medica Bulgarica 2023;50(4):73 View
- Miyakoshi T, Ito Y. Assessing the current utilization status of wearable devices in clinical research. Clinical Trials 2024;21(4):470 View
- de Jong A, Zuidgeest M, Santa-Ana-Tellez Y, de Boer A, Gardarsdottir H. Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches. Drug Discovery Today 2024;29(11):104180 View
- Aiyegbusi O, Cruz Rivera S, Kamudoni P, Anderson N, Collis P, Denniston A, Harding R, Hughes S, Khunti K, Kotecha D, Krumholz H, Liu X, McMullan C, Molony-Oates B, Monteiro J, Myles P, Rantell K, Soltys K, Verdi R, Wilson R, Calvert M. Recommendations to promote equity, diversity and inclusion in decentralized clinical trials. Nature Medicine 2024;30(11):3075 View
- Han Y, Su Q, Liu L, Li Y, Huang J. Structural analysis and intelligent classification of clinical trial eligibility criteria based on deep learning and medical text mining. Journal of Biomedical Informatics 2024;160:104753 View